N. Ferrara, H. Gerber, and J. Lecouter, The biology of VEGF and its receptors, Nature Medicine, vol.99, issue.21, pp.669-676, 2003.
DOI : 10.1073/pnas.152324099

N. Ferrara and T. Davis-smyth, The Biology of Vascular Endothelial Growth Factor, Endocrine Reviews, vol.18, issue.1, pp.4-25, 1997.
DOI : 10.1210/edrv.18.1.0287

D. Bates and S. Harper, Regulation of vascular permeability by vascular endothelial growth factors, Vascular Pharmacology, vol.39, issue.4-5, pp.225-237, 2002.
DOI : 10.1016/S1537-1891(03)00011-9

M. Toi, S. Hoshina, T. Takayanagi, and T. Tominaga, Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer, Japanese Journal of Cancer Research, vol.3, issue.10, pp.1045-1049, 1994.
DOI : 10.1006/bbrc.1993.1955

Y. Hojo, U. Ikeda, Y. Zhu, M. Okada, and S. Ueno, Expression of vascular endothelial growth factor in patients with acute myocardial infarction, Journal of the American College of Cardiology, vol.35, issue.4, pp.968-973, 2000.
DOI : 10.1016/S0735-1097(99)00632-4

M. Slevin, J. Krupinski, A. Slowik, P. Kumar, and A. Szczudlik, Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-??1 in Serum of Patients With Acute Ischemic Stroke, Stroke, vol.31, issue.8, pp.1863-1870, 2000.
DOI : 10.1161/01.STR.31.8.1863

B. Chin, N. Chung, C. Gibbs, A. Blann, and G. Lip, Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure, The American Journal of Cardiology, vol.90, issue.11, pp.1258-1260, 2002.
DOI : 10.1016/S0002-9149(02)02848-5

B. Wirostko, T. Wong, and R. Simo, Vascular endothelial growth factor and diabetic complications, Progress in Retinal and Eye Research, vol.27, issue.6, pp.608-621, 2008.
DOI : 10.1016/j.preteyeres.2008.09.002

W. Lieb, R. Safa, E. Benjamin, V. Xanthakis, and X. Yin, Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function, European Heart Journal, vol.109, issue.9, pp.1121-1127, 2009.
DOI : 10.1042/CS20040307

I. Pantsulaia, S. Trofimov, E. Kobyliansky, and G. Livshits, Heritability of circulating growth factors involved in the angiogenesis in healthy human population, Cytokine, vol.27, issue.6, pp.152-158, 2004.
DOI : 10.1016/j.cyto.2004.04.005

H. Berrahmoune, B. Herbeth, J. Lamont, C. Masson, and P. Fitzgerald, Heritability for Plasma VEGF Concentration in the Stanislas Family Study, Annals of Human Genetics, vol.266, issue.1, pp.54-63, 2007.
DOI : 10.1161/hc0902.104718

S. Debette, S. Visvikis-siest, M. Chen, N. Ndiaye, and C. Song, Identification of cis- and trans-Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels, Circulation Research, vol.109, issue.5, pp.554-563, 2011.
DOI : 10.1161/CIRCRESAHA.111.243790

R. Sladek, G. Rocheleau, J. Rung, C. Dina, and L. Shen, A genome-wide association study identifies novel risk loci for type 2 diabetes, Nature, vol.70, issue.7130, pp.881-885, 2007.
DOI : 10.1038/nature05616

URL : https://hal.archives-ouvertes.fr/hal-00173692

S. Hadjadj, F. Fumeron, R. Roussel, P. Saulnier, and Y. Gallois, Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects: Results from the Non-Insulin-Dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies, Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie Diabete de type 2 et Genetique (SURDIAGENE) studies, pp.1847-1852, 2008.
DOI : 10.2337/dc07-2079

B. Balkau, An epidemiologic survey from a network of French Health Examination Centres): epidemiologic data on the insulin resistance syndrome], Rev Epidemiol Sante Publique, vol.44, pp.373-375, 1996.

S. Hercberg, P. Preziosi, S. Briancon, P. Galan, and I. Triol, A Primary Prevention Trial Using Nutritional Doses of Antioxidant Vitamins and Minerals in Cardiovascular Diseases and Cancers in a General Population, Controlled Clinical Trials, vol.19, issue.4, pp.336-351, 1998.
DOI : 10.1016/S0197-2456(98)00015-4

T. Sparso, A. Bonnefond, E. Andersson, N. Bouatia-naji, and J. Holmkvist, G-allele of Intronic rs10830963 in MTNR1B Confers Increased Risk of Impaired Fasting Glycemia and Type 2 Diabetes Through an Impaired Glucose-Stimulated Insulin Release: Studies Involving 19,605 Europeans, Diabetes, vol.58, issue.6, 2009.
DOI : 10.2337/db08-1660

T. Jorgensen, K. Borch-johnsen, T. Thomsen, H. Ibsen, and C. Glumer, A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99 (1), European Journal of Cardiovascular Prevention & Rehabilitation, vol.7, issue.5, pp.377-386, 2003.
DOI : 10.1093/oxfordjournals.eurheartj.a062065

T. Lauritzen, S. Griffin, K. Borch-johnsen, N. Wareham, and B. Wolffenbuttel, The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening, International Journal of Obesity, vol.24, issue.S3, pp.6-11, 2000.
DOI : 10.1038/sj.ijo.0801420

A. Levey, J. Bosch, J. Lewis, T. Greene, and N. Rogers, A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Annals of Internal Medicine, vol.130, issue.6, pp.461-470, 1999.
DOI : 10.7326/0003-4819-130-6-199903160-00002

T. Wallace, J. Levy, and D. Matthews, Use and Abuse of HOMA Modeling, Diabetes Care, vol.27, issue.6, pp.1487-1495, 2004.
DOI : 10.2337/diacare.27.6.1487

I. Heid, A. Jackson, J. Randall, T. Winkler, and L. Qi, Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution, Nature Genetics, vol.57, issue.11, pp.949-960, 2010.
DOI : 10.1111/j.1420-9101.2005.00917.x

T. Wasada, R. Kawahara, K. Katsumori, M. Naruse, and Y. Omori, Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking, Metabolism, vol.47, issue.1, pp.27-30, 1998.
DOI : 10.1016/S0026-0495(98)90188-3

B. Schrijvers, A. Flyvbjerg, D. Vriese, and A. , The role of vascular endothelial growth factor (VEGF) in renal pathophysiology, Kidney International, vol.65, issue.6, pp.2003-2017, 2004.
DOI : 10.1111/j.1523-1755.2004.00621.x

B. Voight, L. Scott, V. Steinthorsdottir, A. Morris, and C. Dina, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nature Genetics, vol.37, issue.7, pp.579-589, 2010.
DOI : 10.1038/ng.609

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080658/pdf

N. Soranzo, S. Sanna, E. Wheeler, C. Gieger, and D. Radke, Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways, Diabetes, vol.59, issue.12, pp.3229-3239, 2010.
DOI : 10.2337/db10-0502

URL : https://hal.archives-ouvertes.fr/hal-01655345

J. Dupuis, C. Langenberg, I. Prokopenko, R. Saxena, and N. Soranzo, New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk, Nature Genetics, vol.49, issue.2, pp.105-116, 2010.
DOI : 10.1177/002215540104900412

C. Boger, M. Chen, A. Tin, M. Olden, and A. Kottgen, CUBN Is a Gene Locus for Albuminuria, Journal of the American Society of Nephrology, vol.22, issue.3, pp.555-570, 2011.
DOI : 10.1681/ASN.2010060598

J. Ellis, M. Chen, M. Foster, C. Liu, and M. Larson, Validated SNPs for eGFR and their associations with albuminuria, Human Molecular Genetics, vol.478, issue.7, pp.3293-3298, 2012.
DOI : 10.1164/rccm.201102-0192OC

A. Kottgen, C. Pattaro, C. Boger, C. Fuchsberger, and M. Olden, New loci associated with kidney function and chronic kidney disease, Nature Genetics, vol.39, issue.5, pp.376-384, 2010.
DOI : 10.1086/302929

D. Antonetti, R. Klein, and T. Gardner, Diabetic Retinopathy, New England Journal of Medicine, vol.366, issue.13, pp.1227-1239, 2012.
DOI : 10.1056/NEJMra1005073